Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-1,978,650
-
Total reported value, excl. options
-
$0
-
Value change
-
-$419,312
-
Number of sells
-
-30
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q1 2025
32 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q1 2025.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 2,048,819,940 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include NEVILLE RODIE & SHAW INC (0 shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (0 shares), Values First Advisors, Inc. (0 shares), SBI Securities Co., Ltd. (0 shares), Gradient Investments LLC (0 shares), Hibernia Wealth Partners, LLC (0 shares), Tradewinds Capital Management, LLC (0 shares), Weaver Consulting Group (0 shares), LPL Financial LLC (0 shares), and Orin Green Financial, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.